27-04-2021 | 15:17 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news:  Increase in percentage of positive tests, stabilisation in hospital admissions  

Weekly Update 20 April to 27 April 2021

20-04-2021 | 16:00 PM

Vaccination figures: 12 to 18 April 2021

By Sunday 18 April, it is estimated that more than 4.3 million vaccinations had been administered in the Netherlands. More than 3.4 million of those were first vaccinations, and over 900,000 were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.

Go to the weekly update on COVID-19 vaccination.

20-04-2021 | 15:10 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: One in ten tests positive.

Weekly Update 13 April to 20 April 2021

¹GGD reports to RIVMNational Institute for Public Health and the Environment between 13 April10:01 and 20 April 10:00 as published 20 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 6 April 10:01 and 13 April 10:00 as published 13 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 20 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 20 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

13-04-2021 | 10:30 PM

Weekly update on COVID-19 vaccination: 5 to 11 April 2021

The vaccination figures published today in the RIVM report and on the Corona Dashboard are higher than in previous weeks. The news item about the vaccination figures provides further details on this increase.
By Sunday 11 April, it is estimated that nearly 3.8 million vaccinations had been administered in the Netherlands. Almost 3 million of those were first vaccinations, and over 800,000 were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.

Go to the weekly update on COVID-19 vaccination

13-04-2021 | 16:34 PM

Lareb: biweekly report 

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received and reviewed a total of 33,585 reports so far involving 197,652 possible side-effects. About 3.1 million vaccinations have been given by now. Most of the reported symptoms are in line with side-effects that were already known. Since the start of the vaccination campaign, Lareb has received a total of 225 reports regarding deaths shortly after receiving the COVID-19 vaccinations. Most of the reports involved the Pfizer/BioNTech vaccine. It is the COVID-19 vaccine that has been used most frequently, and is also the vaccine used mainly for the elderly. A news item on their website announced that existing health problems were the most likely cause of death in the majority of the reports. 

13-04-2021 | 16:25 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: More positive tests, and rising percentage of positive tests

Weekly Update 7 April to 13 April 2021

¹GGD reports to RIVM between 6 April10:01 and 13 April 10:00 as published 6 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 30 March 10:01 and 6 April 10:00 as published 6 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 13 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 13 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

The number of newly reported infections that RIVM received last week from the Municipal Public Health Services (GGDs) is not the same as the number of positive tests in that week. The number of positive tests during the week could still change in response to delayed reports. These are newly reported infections that originate from test lanes, but also from hospitals and other sources. The number of infections in a week is expected to be higher than the number of positive tests, because it is likely that not everyone who is infected will get tested.

Not everyone who tests positive for COVID-19 is referred to as a patient. That term is used for people who are so ill that they are being monitored by a doctor, or for people who became so ill that they died. Not everyone who tests positive for COVID-19 becomes that ill. Many people only develop mild symptoms, or do not notice any symptoms at all. In the past, people who tested positive for COVID-19 were sometimes referred to as patients. This term has now been updated in our communications.

09-04-2021 | 18:15 PM

Weekly update on COVID-19 vaccination: 21 March to 4 April 2021

By Sunday 4 April, it is estimated that more than 2.8 million vaccinations had been administered in the Netherlands. In week 13, the Netherlands received 326,430 doses of the Pfizer/BioNTech vaccine, 145,200 doses of the Moderna vaccine and 430,320 doses of the AstraZeneca vaccine.

Direct to weekly update on COVID-19 vaccination

06-04-2021 | 16:16 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Fewer cases, higher percentage of positive tests

Weekly Update 31March  to 6 April 2021

¹GGD reports to RIVM between 30 March 10:01 and 6 April 10:00 as published 30 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 23 March 10:01 and 30 March 10:00 as published 30 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 6 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 6 April 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

23-03-2021 | 16:15 PM

Weekly update on COVID-19 vaccination: 14 to 21 March 2021

By Sunday 21 March, it is estimated that nearly 1.5 million people in the Netherlands had received at least one COVID-19 vaccination, and more than 600,000 people had received their second vaccination. The 2 millionth vaccination was administered last week, on 19 March.

Direct to weekly update on COVID-19 vaccination

23-03-2021 | 16:00 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Situation growing worse in the Netherlands

Weekly Update 17 March 2021 to 23 March 2021

* Excluding results from large-scale testing in Bunschoten and Dronten.  If the localised large-scale test results from these locations are included, the percentage of positive tests in the Netherlands is 7.6%. Not including the results from large-scale testing at these locations, the percentage of positive tests in the Netherlands is 8.1%.

¹GGD reports to RIVMNational Institute for Public Health and the Environment between 16 March 10:01 and 23 March 10:00 as published 23 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 9 March 10:01 and 16 March 10:00 as published 16 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 23 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 23 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

16-03-2021 | 16:25 PM

Weekly update on COVID-19 vaccination: 8 to 14 March 2021

By Sunday 14 March, it is estimated that nearly 1.4 million people in the Netherlands had received at least one COVID-19 vaccination, and nearly 500,000 people had received their second vaccination.

Direct to weekly update on COVID-19 vaccination

16-03-2021 | 16:00 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Situation in the Netherlands remains concerning

Weekly Update 10 March 2021 to 16 March 2021

* Excluding results from large-scale testing in Bunschoten and Dronten.  If the localised large-scale test results from these locations are included, the percentage of positive tests in the Netherlands is 7.6%. Not including the results from large-scale testing at these locations, the percentage of positive tests in the Netherlands is 7.7%.

¹GGD reports to RIVM between 9 March 10:01 and 16 March 10:00 as published 16 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 2 March 10:01 and 9 March 10:00 as published 9 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 16 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 16 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

16-03-2021 | 14.00 uur

Lareb: biweekly report 

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received and reviewed a total of 10,887 reports so far involving 57,391 possible side-effects. Nearly 1.9 million vaccinations have been given by now. Most of the reported symptoms are in line with side-effects that were already known. Since the start of the vaccination campaign, Lareb has received a total of 138 reports regarding deaths shortly after receiving the COVID-19 vaccinations. The vast majority involved elderly people who died between 1 and 33 days after the vaccination. Lareb announced in a news item that they were all in vulnerable health due to various serious underlying diseases and/or advanced age. RIVM is monitoring the developments closely.

09-03-2021 | 16:45 PM

Weekly update on COVID-19 vaccination: 28 February  to 7 March 2021

By Sunday 7 March, it is estimated that more than 1.2 million people in the Netherlands had received at least one COVID-19 vaccination, and over 400,000 people had received their second vaccination.

Direct to weekly update on COVID-19 vaccination

09-03-2021 | 16:13 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Number of positive COVID-19 tests at the same level as last week

Weekly Update 2 March 2021 to 9 March 2021

* Excluding results from large-scale testing in Bunschoten, Dronten and the Charlois neighbourhood of Rotterdam.  If the localised large-scale test results from these locations are included, the percentage of positive tests in the Netherlands is 8.0%. Not including the results from large-scale testing at these locations, the percentage of positive tests in the Netherlands is 8.1%.

¹GGD reports to RIVM between 2 March 10:01 and 9 March 10:00 as published 9 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 23 February 10:01 and 2 March 10:00 as published 2 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 2 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 2 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

08-03-2021 | 10:22 AM

CBS: Decrease in mortality among people aged 80 years and up

Based on the national provisional counts of the number of deaths per week, Statistics Netherlands (CBS) estimates that more than 3,200 people died in week 8 (22 to 28 February). This is fewer deaths than expected for this period, and nearly 300 fewer deaths than in the week before (3,491). A significant decrease was seen in mortality among people aged 80 years and up and people receiving care under the Long-Term Care Act (WLZ). 

RIVM also keeps track of mortality figures on a weekly basis, and has been tracking these figures since 2009 in cooperation with Statistics Netherlands. RIVM reports that mortality was elevated in the week of 18 to 24 February in all combined regions, with the exception of the Zeeland/Noord Brabant/Limburg region. A total of 3,348 deaths were reported in that week (354 more than the average expected mortality). We would normally expect to see between 2,830 and 3,157 deaths at this time of year. From 18 to 24 February, the reported mortality due to laboratory-confirmed COVID-19 was 322 deaths.

The method used by RIVM to estimate mortality is slightly different than the method used by Statistics Netherlands. Statistics Netherlands estimates excess mortality based on the average mortality per week in recent years, including increased mortality during unusual circumstances, such as a wave of seasonal influenza, or a heat wave. RIVM does not include the peaks during unusual circumstances in its calculations of average weekly mortality. The excess mortality estimates provided by Statistics Netherlands and RIVM complement each other.

02-03-2021 | 16:47 PM

Weekly update on COVID-19 vaccination: 21 to 28 February 2021

By Sunday 28 February, it is estimated that more than 1,000,000 people in the Netherlands had received at least one COVID-19 vaccination.

Vaccination started last week for mental health clients in inpatient or residential care at four large institutions and the mental healthcare workers employed there; they are being vaccinated by the institution’s own medical department. District nurses also started receiving their vaccinations last week.

Direct to weekly update on COVID-19 vaccination

02-03-2021 | 16:13 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Prospects not looking good yet

Weekly Update 24 February 2021 to 1 March 2021

* Excluding results from large-scale testing in Bunschoten, Dronten and the Charlois neighbourhood of Rotterdam.  If the localised large-scale test results from these locations are included, the percentage of positive tests in the Netherlands is 8.8%. Not including the results from large-scale testing at these locations, the percentage of positive tests in the Netherlands is 8.9%.

¹GGD reports to RIVM between 23 February 10:01 and 2 March 10:00 as published 2 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 16 February 10:01 and 13 February 10:00 as published 23 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 2 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 2 March 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

The number of newly reported infections that RIVM received last week from the Municipal Public Health Services (GGDs) is not the same as the number of positive tests in that week. The number of positive tests during the week could still change in response to delayed reports. These are newly reported infections that originate from test lanes, but also from hospitals and other sources. The number of infections in a week is expected to be higher than the number of positive tests, because it is likely that not everyone who is infected will get tested.

Not everyone who tests positive for COVID-19 is referred to as a patient. That term is used for people who are so ill that they need to be hospitalised, or for people who became so ill that they died. Not everyone who tests positive for COVID-19 becomes so ill that they have to be hospitalised. Many people only develop mild symptoms, or do not notice any symptoms at all.

In the past, we have referred to people who tested positive for COVID-19 as patients. This term has now been updated in our communications.

02-03-2021 | 14:00 PM

Lareb: biweekly report 

In its biweekly report, Pharmacovigilance Centre Lareb stated that the centre had received a total of 6,426 reports so far involving 31,534 possible side-effects. Over 1.3 million vaccinations have been given by now. Most of the reported symptoms are in line with side-effects that were already known. Since the start of the vaccination campaign, Lareb has received a total of 87 reports regarding deaths shortly after receiving the COVID-19 vaccinations. The reports involved elderly people who died between 1 and 26 days after the vaccination. Lareb announced in a news item that these deaths involved were vulnerable elderly people with serious underlying health problems and/or advanced age. RIVM is monitoring the developments closely. 

24-02-2021 I 14:27

OMT advisory report 19 February 2021

The Outbreak Management Team (OMT) convened on 19 February 2021 to advise on the situation surrounding the COVID-19 outbreak. The 101st OMT discussed:

• the course of the epidemic.
• the reproduction rate, effects of measures and prognoses.
• the virus variants.
• the night-time curfew and rule of 1 visitor at home per day.
• the effect of relaxing measures on the spread of the virus.
• relaxation of measures in secondary education, lower secondary vocational education (MBO) and upper secondary education (MBO), higher professional education (HBO) and university education (WO).
• pre-school and after-school care
• relaxation of measures in other sectors.

The OMT advice is published on the website of rijksoverheid.nl. More information about the OMT on the RIVMNational Institute for Public Health and the Environment website. 

23-02-2021 | 16:13 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: Measures prevent more rapid increase, but pressure on hospitals remains high.

Weekly Update 17 February to 23 February 2021

* Excluding results from large-scale testing in Bunschoten, Dronten and the Charlois neighbourhood of Rotterdam.  If the localised large-scale test results from these locations are included, the percentage of positive tests in the Netherlands is 9.7%. Not including the results from large-scale testing at these locations, the percentage of positive tests in the Netherlands is 9.8%.

¹GGD reports to RIVM between 16 February 10:01 and 23 February 10:00 as published 23 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 9 February 10:01 and 16 February 10:00 as published 16 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 23 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 23 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

23-02-2021 | 14.10 PM

Lareb: weekly report 

In its weekly report, Pharmacovigilance Centre Lareb stated that the centre had received a total of 5,068 reports so far involving 24,031 possible side-effects. Over a million vaccinations have been given by now. One-half of a percent of the people who have been vaccinated reported one or more side-effects. Most of the reported symptoms are in line with side-effects that were already known. Since the start of the vaccination campaign, Lareb has received a total of 65 reports regarding deaths shortly after receiving the COVID-19 vaccinations. The reports involved elderly people who died between 1 and 26 days after the vaccination. Lareb announced in a news item (in Dutch) that they were all in vulnerable health due to various serious underlying diseases and/or advanced age. RIVM is monitoring the developments closely. 

9-2-2021 | 16:20 PM

Weekly update on COVID-19 vaccination: 1 to 7 February 2021

By Sunday 7 February, more than 500,000 people in the Netherlands had received their first COVID-19 vaccination. That also includes about 13,600 GPs. Last Friday, the first people in the age group from 80-84 years received an invitation to make an appointment for a COVID-19 vaccination at a Municipal Public Health Service (GGD).

Direct to weekly update on COVID-19 vaccination

09-02-2021 | 16:05 PM

For an explanation of the weekly COVID-19 figures, read the news: 

Weekly Update 3 February to 9 February 2021

¹GGD reports to RIVM between 2 February 10:01 and 9 February 10:00 as published 9 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 25 January 10:01 and 2 February 10:00 as published 2 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 9 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week.
_⁵ As published 9 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

02-02-2021 | 16:10 PM

RIVM joins European project on response to pandemics

Starting in February 2021, RIVM and Radboud University Medical Centre will be collaborating on the PANDEM-2 project. This project aims to increase and strengthen preparedness for and response to future pandemics. In that context, sharing information and collaborating are very important in order to protect the health and safety of people across the European Union. The PANDEM-2 project is funded by the European Union through Horizon 2020. The team from the Netherlands includes experts from Radboudumc and RIVM.

Read the Radboudumc press release (in Dutch)

02-02-2021 | 16:05 PM

For an explanation of the weekly COVID-19 figures, read the news: New variants disrupt plans

Weekly Update 27 January to 2 February 2021

*Excluding results from the municipality of Lansingerland due to large-scale testing in Lansingerland.

¹GGD reports to RIVM between 26 January 10:01 and 2 February 10:00 as published 2 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 19 January 10:01 and 26 January 10:00 as published 26 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 2 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week
_⁵ As published 2 February 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

29-1-2021 | 12:20 PM

Statistics Netherlands (CBS): Mortality still elevated: 3,800 deaths in week 3

Statistics Netherlands (CBS) reports in week 3 (18 to 24 January inclusive) that an estimated 3,850 people have died in the Netherlands. This is 450 more deaths than would normally be expected in this period. RIVMNational Institute for Public Health and the Environment   also keeps track of mortality figures on a weekly basis (in Dutch). In the most recent RIVM data for 14 until 20 January, mortality was slightly elevated in the age category of 65 - 74 years and highly elevated in the age category 75 years and older. Mortality was higher in all combined regions.

26-1-2021 | 17:09 PM

More than 160 thousand people vaccinated in total

During the week of 18 to 24 January, more than 80 thousand people were vaccinated. Most of these were mainly care workers. Residents of institutions for people with intellectual disabilities and nursing homes also received their first vaccination. All vaccinated people still need to receive a second vaccination for optimal protection. As of 19 January, RIVM is publishing a weekly update on figures from the COVID-19 vaccination programme.

26-1-2021 | 16:35 PM

For an explanation of the weekly COVID-19 figures, read the news: UK variant gains ground in the Netherlands

Weekly Update 20 to 26 January 2021

*Excluding results from the municipality of Lansingerland due to large-scale testing in Lansingerland. If the localised large-scale test results from Lansingerland are included, the percentage of positive tests in the Netherlands is 11.0%. Not including the tests from Lansingerland, the percentage of positive tests in the Netherlands is 11.7%.

¹GGD reports to RIVM between 19 January 10:01 and 26 January 10:00 as published 26 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 12 January 10:01 and 19 January 10:00 as published 19 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 26 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ Not all of these reported deaths of COVID-19 patients occurred within the last week
_⁵ As published 26 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

19-1-2021 | 16:22 PM

Weekly RIVM update on vaccination figures

As of today, RIVM will be publishing an update every Tuesday on figures from the COVID-19-vaccination programme. Initial figures on the number of vaccinations that have been administered will be reported this week. The data will be updated and supplemented in the next few weeks. Eventually, the data will also be available in open data sets and on the coronavirus dashboard provided by the Dutch Government.

Read more

19-1-2021 | 16:00 PM

For an explanation of the weekly COVID-19 figures, read the news: Rise in new COVID-19 variants overshadows more positive developments

Weekly Update 13 to 19 January 2021

Not all of the reported hospital admissions or deaths occurred within the last week

*Excluding results from the municipality of Lansingerland due to large-scale testing in Lansingerland. If the localised large-scale test results from Lansingerland are included, the percentage of positive tests in the Netherlands is 11.0%. Not including the tests from Lansingerland, the percentage of positive tests in the Netherlands is 11.7%.

¹GGD reports to RIVM between 12 January 10:01 and 19 January 10:00 as published 19 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
²GGD reports to RIVM between 5 January 10:01 and 12 January 10:00 as published 12 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published 19 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
_⁴ As published 19 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

18-1-2021 | 17:40 PM

Study on Q fever and COVID-19

On Thursday 14 January 2021, RIVM National Institute for Public Health and the Environment   launched a study on Q fever and COVID-19 in the province of Noord-Brabant. Working with the Hart voor Brabant Municipal Public Health Service (GGD) and the Jeroen Bosch Hospital, among other parties, RIVM is researching whether people who had Q fever in 2007–2009 also have a higher risk of contracting COVID-19. Targeted invitations will be sent to potential participants for this study.

More information Q fever and COVID-19

12-1-2021 | 16:00 PM

For an explanation of the weekly COVID-19 figures, read the news: Tentative decrease becomes visible

Weekly Update 6 to 12 January 2021

Not all of the reported hospital admissions or deaths occurred within the last 24 hours

¹ GGD reports to RIVM National Institute for Public Health and the Environment   between 5 January10:01 and 12 January 10:00 as published 12 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
² GGD reports to RIVM between 29 December 10:01 and 5 January 10:00 as published 5 January 2020 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published  12 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ As published  12 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later by the NICE Foundation.

5-1-2021 | 15:45 PM

For an explanation of the weekly COVID-19 figures, read the news: Decisive decrease not yet visible

Weekly Update 30 December 2020 - 5 January 2021

Not all of the reported hospital admissions or deaths occurred within the last 24 hours

¹ GGD reports to RIVM National Institute for Public Health and the Environment   between 29 December 10:01 and 5 January 10:00 as published 5 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
² GGD reports to RIVM between 22 December 10:01 and 29 December 10:00 as published 29 December 2020 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
³ As published  5 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any registrations provided later by the NICE Foundation.
⁴ As published  5 January 2021 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later.